L-Glutamine for Gut Barrier Support — Gut
Conditionally essential amino acid that is the primary fuel source for enterocytes, with moderate evidence for gut barrier integrity and intestinal permeability.
Overview
L-Glutamine is the most abundant free amino acid in the human body, with plasma concentrations of 500-900 micromol/L. While classified as non-essential under normal conditions, glutamine becomes conditionally essential during physiological stress, critical illness, intense exercise, and GI pathology when demand exceeds synthetic capacity. Glutamine is the primary metabolic fuel for enterocytes (intestinal epithelial cells), lymphocytes, and macrophages — it is oxidized as rapidly as glucose by these cells. In the gut, glutamine is essential for maintaining tight junction protein expression (claudins, occludin, ZO-1), mucin production by goblet cells, and proliferation of intestinal stem cells. Clinical evidence supports glutamine supplementation for reducing intestinal permeability ('leaky gut') in critically ill patients (multiple RCTs), improving gut barrier function during chemotherapy-induced mucositis, and reducing infectious complications in surgical ICU patients. A meta-analysis of parenteral glutamine in ICU patients showed reduced mortality and infectious complications. For functional GI conditions, oral glutamine (5 g three times daily) significantly reduced intestinal permeability and IBS-D symptom severity in a randomized controlled trial of post-infectious IBS. Glutamine also supports mucosal immune function by maintaining secretory IgA production and lymphocyte proliferation in gut-associated lymphoid tissue (GALT).
Indications
- Moderate evidence: Gut barrier integrity and intestinal permeability reduction
- Moderate evidence: Chemotherapy-induced mucositis prevention and treatment
- Moderate evidence: ICU/critical illness — reduced infectious complications (parenteral)
- Moderate evidence: Post-infectious IBS (IBS-D) symptom improvement
- Moderate evidence: Exercise-induced intestinal permeability prevention
- Emerging evidence: Inflammatory bowel disease adjunctive support
Mechanism of Action
Glutamine is the primary oxidative fuel for intestinal epithelial cells, providing 70% of their energy through glutaminolysis in the mitochondria
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| L-Glutamine powder | 5 g | Once daily | General gut barrier support and maintenance |
| L-Glutamine powder | 5 g | Three times daily | IBS/increased permeability; used in RCT for post-infectious IBS |
| L-Glutamine powder | 10 g | Twice daily | Intensive gut repair protocol; exercise-induced permeability |
| L-Glutamine | 0.3-0.5 g/kg/day | Divided doses | Critical illness/mucositis dosing; weight-based |
Evidence Grade
GRADE B
Safety & Contraindications
- Well tolerated at oral doses up to 30 g/day in clinical trials
- May be contraindicated in hepatic encephalopathy (ammonia concern)
- Theoretical concern in cancer — glutamine fuels rapidly dividing cells; oncology use remains debated
- GI bloating possible at high doses (>15 g single dose)
- Renal-impaired patients may accumulate glutamate — use caution
- Powder form mixes easily in water; unflavored and nearly tasteless